BNTC

Benitec BiopharmaD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-22

View Chart

Current thesis

Composite grade D from latest DB weights. Momentum 41.0 / Value 41.1

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.0.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-07-22

Fundamentals

As of 2026-07-22 • Vendor: Data Vendor v1

Scores

As of 2026-07-22 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-07-22

Supporting evidence

What

Grade D · Defensive

Confidence Medium · Net Neutral

Target $25.80

Why

Momentum41 · Δ7d -13.5

Value41 · Δ7d -0.0

SentimentN/A · Δ7d -

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Lead driver: Value · See fundamentals

Momentum

40% active weight

Current posture

7d trendSoftening

Δ7d

-13.5

Δ21d

+28.7

Value

60% active weight

Current posture

7d trendFlat

Δ7d

-0.0

Δ21d

-0.1

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade D. Momentum 41.0 / Value 41.1

Fundamentals (TTM)

As of 2026-07-22

Market Cap

$393.01M

Beta

0.26

Shares Out

34.35M

P/E (TTM) · Derived

-0.8

P/S (TTM)

P/FCF (TTM) · Derived

-24.37

Rev YoY

-100.0%

EPS YoY

-35.7%

Gross Margin

-4700.0%

Op Margin

Net Debt

-$97.01M

Current Ratio

56.82

As of 2026-07-22 • Updated nightlySource: Internal modelMethodology